XY0YX28Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8

New Technology›Extracorporeal›Introduction

Billable / Specific Code

ICD-10-PCS XY0YX28

CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.

XY0YX28 is a billable ICD-10-PCS procedure code for Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code

XY0YX28

Billable Status

Yes — Valid for Submission

Code Describes

Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8

Parent Code

XY0 New Technology, Extracorporeal, Introduction

Short Description

Extracorporeal Introduce of Taurolidine/Heparin, New Tech 8

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

Position	Designation	Value	Meaning
1	Section	X	New Technology
2	Body System	Y	Extracorporeal
3	Operation	0	Introduction
4	BodyPart	Y	Extracorporeal
5	Approach	X	External
6	Device/Substance/Technology	2	Taurolidine Anti-infective and Heparin Anticoagulant
7	Qualifier	8	New Technology Group 8

Similar Procedure Codes

Questions About XY0YX28

Is XY0YX28 a billable code?

Yes. XY0YX28 is a complete seven-character ICD-10-PCS code, specific enough to report Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XY0YX28 mean?

XY0YX28 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character Y is the Body System (Extracorporeal); the 3rd character 0 is the Operation (Introduction); the 4th character Y is the BodyPart (Extracorporeal); the 5th character X is the Approach (External); the 6th character 2 is the Device/Substance/Technology (Taurolidine Anti-infective and Heparin Anticoagulant); the 7th character 8 is the Qualifier (New Technology Group 8).